Fisherman JS - Search Results

1

Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer.

Fisherman JS, Cowan KH, Noone M, Denicoff A, Berg S, Poplack D, Balis F, Venzon D, McCabe M, Goldspiel B, Chow C, Ognibene FP, O'Shaughnessy J. Fisherman JS, et al. J Clin Oncol. 1996 Mar;14(3):774-82. doi: 10.1200/JCO.1996.14.3.774. J Clin Oncol. 1996. PMID: 8622023 Clinical Trial.

2

Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer.

O'Shaughnessy JA, Fisherman JS, Cowan KH. O'Shaughnessy JA, et al. Among authors: fisherman js. Semin Oncol. 1994 Oct;21(5 Suppl 8):19-23. Semin Oncol. 1994. PMID: 7939757 Review.

3

Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer.

Pestalozzi BC, Sotos GA, Choyke PL, Fisherman JS, Cowan KH, O'Shaughnessy JA. Pestalozzi BC, et al. Among authors: fisherman js. Cancer. 1993 Mar 1;71(5):1797-800. doi: 10.1002/1097-0142(19930301)71:5<1797::aid-cncr2820710514>3.0.co;2-b. Cancer. 1993. PMID: 8095437

4

Phase I study of Taxol, doxorubicin, plus granulocyte-colony stimulating factor in patients with metastatic breast cancer.

Fisherman JS, McCabe M, Noone M, Ognibene FP, Goldspiel B, Venzon DJ, Cowan KH, O'Shaughnessy JA. Fisherman JS, et al. J Natl Cancer Inst Monogr. 1993;(15):189-94. J Natl Cancer Inst Monogr. 1993. PMID: 7517154 Clinical Trial.

5

Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion.

Berg SL, Cowan KH, Balis FM, Fisherman JS, Denicoff AM, Hillig M, Poplack DG, O'Shaughnessy JA. Berg SL, et al. Among authors: fisherman js. J Natl Cancer Inst. 1994 Jan 19;86(2):143-5. doi: 10.1093/jnci/86.2.143. J Natl Cancer Inst. 1994. PMID: 7903702 No abstract available.

6

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

Trimble EL, Adams JD, Vena D, Hawkins MJ, Friedman MA, Fisherman JS, Christian MC, Canetta R, Onetto N, Hayn R, et al. Trimble EL, et al. Among authors: fisherman js. J Clin Oncol. 1993 Dec;11(12):2405-10. doi: 10.1200/JCO.1993.11.12.2405. J Clin Oncol. 1993. PMID: 7902426 Clinical Trial.

7

Cardiac disturbances during the administration of taxol.

Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC. Rowinsky EK, et al. Among authors: fisherman js. J Clin Oncol. 1991 Sep;9(9):1704-12. doi: 10.1200/JCO.1991.9.9.1704. J Clin Oncol. 1991. PMID: 1678781

8

Clinical development of Taxol.

Arbuck SG, Christian MC, Fisherman JS, Cazenave LA, Sarosy G, Suffness M, Adams J, Canetta R, Cole KE, Friedman MA. Arbuck SG, et al. Among authors: fisherman js. J Natl Cancer Inst Monogr. 1993;(15):11-24. J Natl Cancer Inst Monogr. 1993. PMID: 7912517 Review.

9

Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials.

Fisherman JS, Osborn BL, Chun HG, Plowman J, Smith AC, Christian MC, Zaharko DS, Shoemaker RH. Fisherman JS, et al. Invest New Drugs. 1993 Feb;11(1):1-9. doi: 10.1007/BF00873904. Invest New Drugs. 1993. PMID: 8349430 Review.

10

Terephthalamidine: past and future.

Fisherman JS, Cline EM, Plowman J, Quinn FR, Hawkins MJ. Fisherman JS, et al. Invest New Drugs. 1991 Nov;9(4):295-303. doi: 10.1007/BF00183569. Invest New Drugs. 1991. PMID: 1804802 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page